Chemical Engineering and Structural and Pharmacological Characterization of the α-Scorpion Toxin OD1
Thomas Durek(The University of Queensland), Paul F. Alewood(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands)), Ching-I Anderson Wang(The University of Queensland), Oliver Knapp(RMIT University), Irina Vetter(Centre National de la Recherche Scientifique), Leonid Motin(RMIT University), David J. Adams(University of Wollongong)
Cited by 56
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422